|
1 | 2 |
3 | 4 | 5
| 6
| 7 | 8 |
表2．薬剤耐性菌別感染患者数
| 薬剤耐性菌別感染 |
10月
|
11月
|
12月
|
合計
|
||||
| MRSA |
434
|
(93.1%)
|
401
|
(92.6%)
|
472
|
(93.8%)
|
1,307
|
(93.2%)
|
| PRSP (PISPも含む） |
18
|
(3.9%)
|
18
|
(4.2%)
|
21
|
(4.2%)
|
57
|
(4.1%)
|
| 多剤耐性緑膿菌 |
8
|
(1.7%)
|
6
|
(1.4%)
|
6
|
(1.2%)
|
20
|
(1.4%)
|
| メタロβラクタマーゼ産生グラム陰性桿菌 |
1
|
(0.2%)
|
6
|
(1.4%)
|
3
|
(0.6%)
|
10
|
(0.7%)
|
| MRSA＋多剤耐性緑膿菌 |
3
|
(0.6%)
|
2
|
(0.5%)
|
0
|
(0.0%)
|
5
|
(0.4%)
|
| MRSA＋メタロβラクタマーゼ産生グラム陰性桿菌 |
0
|
(0.0%)
|
0
|
(0.0%)
|
0
|
(0.0%)
|
0
|
(0.0%)
|
| VRE |
2
|
(0.4%)
|
0
|
(0.0%)
|
1
|
(0.2%)
|
3
|
(0.2%)
|
| VRSA |
0
|
(0.0%)
|
0
|
(0.0%)
|
0
|
(0.0%)
|
0
|
(0.0%)
|
| 感染患者数計 |
466
|
(100.0%)
|
433
|
(100.0%)
|
503
|
(100.0%)
|
1,402
|
(100.0%)
|
| 参加施設数 |
124
|
147
|
146
|
----
|
||||
